Pharmaceutical compositions of roflumilast in aqueous blends of water-miscible, pharmaceutically acceptable solvents
AssigneeArcutis Biotherapeutics, Inc.
InventorDavid W. Osborne
Life of this patent
Estimating the term…
Abstract
The low aqueous solubility of roflumilast in parenteral preparations and topical emulsions, suspensions, gels or solutions can be improved by including a blend of water-miscible solvents in the pharmaceutical composition. The blend of water-miscible solvents can include diethylene glycol monoethyl ether (Tradename Transcutol®; abbreviated DEGEE) and water. The ratio of diethylene glycol monoethyl ether to water is from 1:10 to 20:1. The resulting composition has improved bioavailability and efficacy and can be used to inhibit phosphodiesterase 4 in a patient in need of such treatment.
Claims2
A pharmaceutical composition consisting of roflumilast, white petrolatum, isopropyl palmitate, an emulsifier blend of cetearyl alcohol, dicetyl phosphate and ceteth-10 phosphate, hexylene glycol, N-methyl pyrrolidone, diethyl glycol monoethyl ether, methylparaben, propylparaben and water in the following proportions:
- Roflumilast 0.5% w/w
- White Petrolatum 10.0% w/w
- Isopropyl Palmitate 5.0% w/w
- Emulsifier blend 10.0% w/w
- Hexylene glycol 8.0% w/w
- N-methyl pyrrolidone 12.0% w/w
- Diethylene glycol monoethyl ether 25.0% w/w
- Methylparaben 0.2% w/w
- Propylparaben 0.05% w/w
- Purified Water q.s. ad 100.
A pharmaceutical composition consisting of roflumilast, white petrolatum, isopropyl palmitate, an emulsifier blend of cetearyl alcohol, dicetyl phosphate and ceteth-10 phosphate, hexylene glycol, diethyl glycol monoethyl ether, methylparaben, propylparaben, and water, in the following proportions:
- Roflumilast 0.5% w/w
- White Petrolatum 10.0% w/w
- Isopropyl Palmitate 5.0% w/w
- Emulsifier blend 10.0% w/w
- Hexylene glycol 2.0% w/w
- Diethylene glycol monoethyl ether 25.0% w/w
- Methylparaben 0.2% w/w
- Propylparaben 0.05% w/w
- Purified Water q.s. ad 100
- wherein said composition does not contain undissolved roflumilast.
Dependencies are inferred from the claim text.